Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 55 articles:
HTML format



Single Articles


    May 2022
  1. MARRAZZO J
    Lenacapavir for HIV-1 - Potential Promise of a Long-Acting Antiretroviral Drug.
    N Engl J Med. 2022;386:1848-1849.
    PubMed    


  2. SEGAL-MAURER S, DeJesus E, Stellbrink HJ, Castagna A, et al
    Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
    N Engl J Med. 2022;386:1793-1803.
    PubMed     Abstract available


  3. GRAY G, Collie S, Goga A, Garrett N, et al
    Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMc2202061.
    PubMed    


    April 2022
  4. MOORE PL, Baden LR
    Omicron - Decoupling Infection from Severe Disease.
    N Engl J Med. 2022;386:1361-1362.
    PubMed    


    March 2022
  5. JARVIS JN, Lawrence DS, Meya DB, Kagimu E, et al
    Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    N Engl J Med. 2022;386:1109-1120.
    PubMed     Abstract available


  6. LUEKING R, Lazarte S
    Malignant Syphilis.
    N Engl J Med. 2022;386:e26.
    PubMed    


  7. OZELO MC, Mahlangu J, Pasi KJ, Giermasz A, et al
    Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
    N Engl J Med. 2022;386:1013-1025.
    PubMed     Abstract available


  8. TURKOVA A, Wills GH, Wobudeya E, Chabala C, et al
    Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.
    N Engl J Med. 2022;386:911-922.
    PubMed     Abstract available


  9. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, AlMukdad S, et al
    Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMoa2200797.
    PubMed     Abstract available


    February 2022
  10. SILVERMAN RF, Shinder R
    Molluscum Contagiosum.
    N Engl J Med. 2022;386:582.
    PubMed    


    January 2022
  11. ATMAR RL, Lyke KE, Deming ME, Jackson LA, et al
    Homologous and Heterologous Covid-19 Booster Vaccinations.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMoa2116414.
    PubMed     Abstract available


    December 2021
  12. TURKOVA A, White E, Mujuru HA, Kekitiinwa AR, et al
    Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
    N Engl J Med. 2021;385:2531-2543.
    PubMed     Abstract available


  13. COLLIE S, Champion J, Moultrie H, Bekker LG, et al
    Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMc2119270.
    PubMed    


  14. CATTAMANCHI A, Reza TF, Nalugwa T, Adams K, et al
    Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.
    N Engl J Med. 2021;385:2441-2450.
    PubMed     Abstract available


  15. BOR J, Onoya D, Richman B, Mayer KH, et al
    A Failure to Disseminate Transformative Science - HIV Treatment as Prevention, 10 Years On.
    N Engl J Med. 2021;385:2305-2307.
    PubMed    


  16. BRAVO MS
    Emperor of the Empire.
    N Engl J Med. 2021;385:2215-2217.
    PubMed    


    November 2021
  17. DIETZ BW, Winston LG, Koehler JE, Margaretten M, et al
    Copycat.
    N Engl J Med. 2021;385:1797-1802.
    PubMed    


    October 2021
  18. TSENG ZH, Hsue PY, Moffatt E
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV. Reply.
    N Engl J Med. 2021;385:e50.
    PubMed    


  19. OLALLA J, Pombo M
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed    


  20. KLEIN MD, Keen SK, Simpson RJ Jr
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed    


  21. CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
    Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
    PubMed     Abstract available


    September 2021
  22. SAAG MS
    HIV Infection - Screening, Diagnosis, and Treatment. Reply.
    N Engl J Med. 2021;385:1344.
    PubMed    


  23. DE SOCIO GV
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;385:1344.
    PubMed    


  24. LEINER S
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;385:1343-1344.
    PubMed    


  25. BAYER R, Oppenheimer GM, Parisi V
    Marking the 40th Anniversary of the AIDS Epidemic - American Physicians Look Back.
    N Engl J Med. 2021;385:1251-1253.
    PubMed    


  26. GOUVEIA-MORAES F, Campos N
    Conjunctival Kaposi's Sarcoma.
    N Engl J Med. 2021;385:e36.
    PubMed    


  27. NEILAN AM, Salvant Valentine S, Knopf AS
    Case 27-2021: A 16-Year-Old Boy Seeking Human Immunodeficiency Virus Prophylaxis.
    N Engl J Med. 2021;385:1034-1041.
    PubMed    


    August 2021
  28. PURUSHOTHAMAN S, Mayakuntla B
    Circinate Syphilitic Lesions.
    N Engl J Med. 2021;385:e26.
    PubMed    


  29. ABDOOL KARIM Q
    Enhancing HIV Prevention with Injectable Preexposure Prophylaxis.
    N Engl J Med. 2021;385:652-653.
    PubMed    


  30. LANDOVITZ RJ, Donnell D, Clement ME, Hanscom B, et al
    Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
    N Engl J Med. 2021;385:595-608.
    PubMed     Abstract available


  31. GOLDSTEIN RH, Mehan WA, Hutchison B, Robbins GK, et al
    Case 24-2021: A 63-Year-Old Woman with Fever, Sore Throat, and Confusion.
    N Engl J Med. 2021;385:641-648.
    PubMed    


  32. COREY L, Beyrer C, Cohen MS, Michael NL, et al
    SARS-CoV-2 Variants in Patients with Immunosuppression.
    N Engl J Med. 2021;385:562-566.
    PubMed    


    July 2021
  33. PATON NI, Musaazi J, Kityo C, Walimbwa S, et al
    Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.
    N Engl J Med. 2021;385:330-341.
    PubMed     Abstract available


    June 2021
  34. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    SARS-CoV-2 Variants and Vaccines.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMsr2105280.
    PubMed     Abstract available


  35. TSENG ZH, Moffatt E, Kim A, Vittinghoff E, et al
    Sudden Cardiac Death and Myocardial Fibrosis, Determined by Autopsy, in Persons with HIV.
    N Engl J Med. 2021;384:2306-2316.
    PubMed     Abstract available


  36. SAAG MS
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;384:2131-2143.
    PubMed    


    May 2021
  37. RUBIN EJ, Baden LR, Gray GE, Morrissey S, et al
    Audio Interview: Vaccination and Variants in the U.S. and South Africa.
    N Engl J Med. 2021;384:e85.
    PubMed    


  38. DORMAN SE, Nahid P, Kurbatova EV, Phillips PPJ, et al
    Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
    N Engl J Med. 2021;384:1705-1718.
    PubMed     Abstract available


  39. SHINDE V, Bhikha S, Hoosain Z, Archary M, et al
    Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMoa2103055.
    PubMed     Abstract available


    April 2021
  40. KATZ IT, Weintraub R, Bekker LG, Brandt AM, et al
    From Vaccine Nationalism to Vaccine Equity - Finding a Path Forward.
    N Engl J Med. 2021;384:1281-1283.
    PubMed    


  41. NORASETHASOPON T, Boonyagars L
    Talaromycosis.
    N Engl J Med. 2021;384:1261.
    PubMed    


    March 2021
  42. QUINN SC, Andrasik MP
    Addressing Vaccine Hesitancy in BIPOC Communities - Toward Trustworthiness, Partnership, and Reciprocity.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103104.
    PubMed    


  43. NACHEGA JB, Sam-Agudu NA, Mellors JW, Zumla A, et al
    Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313.
    PubMed    


  44. FEINBERG MB
    Uhambo - Twists and Turns on the Journey to an Efficacious HIV-1 Vaccine.
    N Engl J Med. 2021;384:1157-1159.
    PubMed    


  45. GRAY GE, Bekker LG, Laher F, Malahleha M, et al
    Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
    N Engl J Med. 2021;384:1089-1100.
    PubMed     Abstract available


  46. WALKER BD
    The AMP Trials - A Glass Half Full.
    N Engl J Med. 2021;384:1068-1069.
    PubMed    


  47. COREY L, Gilbert PB, Juraska M, Montefiori DC, et al
    Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
    N Engl J Med. 2021;384:1003-1014.
    PubMed     Abstract available


  48. THAMMAVARANUCUPT K, Spanuchart I
    Sulfonamide Crystals.
    N Engl J Med. 2021;384:1053.
    PubMed    


  49. MADHI SA, Baillie V, Cutland CL, Voysey M, et al
    Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMoa2102214.
    PubMed     Abstract available


    December 2020
  50. HELLER HM, Gonzalez RG, Edlow BL, Ard KL, et al
    Case 40-2020: A 24-Year-Old Man with Headache and Covid-19.
    N Engl J Med. 2020;383:2572-2580.
    PubMed    


  51. PAN H, Peto R, Henao-Restrepo AM, Preziosi MP, et al
    Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMoa2023184.
    PubMed     Abstract available


  52. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMp2033538.
    PubMed    


    November 2020
  53. MITJA O, Corbacho-Monne M, Ubals M, Alemany A, et al
    A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
    N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMoa2021801.
    PubMed     Abstract available


    October 2020
  54. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 and the President.
    N Engl J Med. 2020;383:e104.
    PubMed    


  55. CELUM C, Barnabas R, Cohen MS, Collier A, et al
    Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2022269.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: